pharmacological profiles of new olivacine related compounds, possessing a modified Dring. The impact of this modification has been evaluated with respect to the cytotoxic and in vivo antitumoral effects of these molecules and in comparison with parent S 16020-2 previously prepared and investigated in our laboratory. The Dring size and number of nitrogen atoms as well as the position of the aminoalkyl substituent